305 related articles for article (PubMed ID: 11962669)
1. From circadian rhythms to cancer chronotherapeutics.
Lévi F
Chronobiol Int; 2002 Jan; 19(1):1-19. PubMed ID: 11962669
[TBL] [Abstract][Full Text] [Related]
2. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
[TBL] [Abstract][Full Text] [Related]
3. [Chronopharmacology and chronotherapy of cancers].
Lévi F
Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
[TBL] [Abstract][Full Text] [Related]
4. Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F
Cancer Causes Control; 2006 May; 17(4):611-21. PubMed ID: 16596317
[TBL] [Abstract][Full Text] [Related]
5. The circadian timing system, a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics.
Lévi F
Conf Proc IEEE Eng Med Biol Soc; 2006; Suppl():6736-9. PubMed ID: 17959499
[TBL] [Abstract][Full Text] [Related]
6. It is time for chronotherapy!
Coudert B; Bjarnason G; Focan C; di Paola ED; Lévi F
Pathol Biol (Paris); 2003 Jun; 51(4):197-200. PubMed ID: 12852987
[TBL] [Abstract][Full Text] [Related]
7. Cancer chronotherapy: principles, applications, and perspectives.
Mormont MC; Levi F
Cancer; 2003 Jan; 97(1):155-69. PubMed ID: 12491517
[TBL] [Abstract][Full Text] [Related]
8. It's time for chronotherapy!
Coudert B; Focan C; Donato di Paola E; Lévi F;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S50-3. PubMed ID: 11858965
[TBL] [Abstract][Full Text] [Related]
9. The circadian timing system in clinical oncology.
Innominato PF; Roche VP; Palesh OG; Ulusakarya A; Spiegel D; Lévi FA
Ann Med; 2014 Jun; 46(4):191-207. PubMed ID: 24915535
[TBL] [Abstract][Full Text] [Related]
10. [The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
Lévi F
Ann Pharm Fr; 2008 Jun; 66(3):175-84. PubMed ID: 18706346
[TBL] [Abstract][Full Text] [Related]
11. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F; Altinok A; Clairambault J; Goldbeter A
Philos Trans A Math Phys Eng Sci; 2008 Oct; 366(1880):3575-98. PubMed ID: 18644767
[TBL] [Abstract][Full Text] [Related]
12. Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer Chronotherapy.
Lévi F; Giacchetti S; Adam R; Zidani R; Metzger G; Misset JL
Eur J Cancer; 1995; 31A(7-8):1264-70. PubMed ID: 7577034
[TBL] [Abstract][Full Text] [Related]
13. Tumor-based rhythms of anticancer efficacy in experimental models.
Granda TG; Lévi F
Chronobiol Int; 2002 Jan; 19(1):21-41. PubMed ID: 11962677
[TBL] [Abstract][Full Text] [Related]
14. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics.
Lévi F; Filipski E; Iurisci I; Li XM; Innominato P
Cold Spring Harb Symp Quant Biol; 2007; 72():465-75. PubMed ID: 18419306
[TBL] [Abstract][Full Text] [Related]
15. Systems Chronotherapeutics.
Ballesta A; Innominato PF; Dallmann R; Rand DA; Lévi FA
Pharmacol Rev; 2017 Apr; 69(2):161-199. PubMed ID: 28351863
[TBL] [Abstract][Full Text] [Related]
16. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.
Ortiz-Tudela E; Mteyrek A; Ballesta A; Innominato PF; Lévi F
Handb Exp Pharmacol; 2013; (217):261-88. PubMed ID: 23604483
[TBL] [Abstract][Full Text] [Related]
17. Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics.
Lévi F; Okyar A
Expert Opin Drug Deliv; 2011 Dec; 8(12):1535-41. PubMed ID: 22097903
[TBL] [Abstract][Full Text] [Related]
18. Chronotherapy for gastrointestinal cancers.
Lévi F
Curr Opin Oncol; 1996 Jul; 8(4):334-41. PubMed ID: 8869810
[TBL] [Abstract][Full Text] [Related]
19. Circadian rhythms: mechanisms and therapeutic implications.
Levi F; Schibler U
Annu Rev Pharmacol Toxicol; 2007; 47():593-628. PubMed ID: 17209800
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implications of circadian rhythms in cancer patients.
Lévi F
Novartis Found Symp; 2000; 227():119-36; discussion 136-42. PubMed ID: 10752068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
